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ABSTRACT
While invasive aspergillosis occurs typically in severely immunocompromised patients, cases of surgical
site infection have been reported in immunocompetent individuals. The Medline, LILACS and EMBASE
databases were searched for descriptions of cases of post-operative aspergillosis, and references from
relevant articles and conference abstracts were reviewed. More than 500 cases of post-operative
aspergillosis were found. Cardiac surgery (n = 188), ophthalmological surgery (n > 90) and dental
surgery (n > 100) were associated with the majority of cases. Other cases involved wound infections
(n = 22), bronchial infections (n = 30), mediastinitis (n = 11), pleural aspergillosis (n = 1), infections
following orthopaedic surgery (n = 42), vascular prosthetic surgery (n = 22), breast surgery (n = 5),
abdominal surgery (n = 10) and neurosurgery (n = 25). In most patients, the source was presumed to be
airborne infection during the surgical procedure. Prevention of these infections requires special care of
the ventilation system in the operating room. Successful treatment requires rapid diagnosis, surgical
debridement and antifungal therapy, often with voriconazole. In order to improve the outcome, better
diagnostic methods are needed, particularly for cases of endocarditis and aortitis.
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INTRODUCTION
Fungi belonging to the genus Aspergillus are
ubiquitous and occur in soil, water and decaying
vegetation [1,2]. Like other ﬁlamentous fungi,
Aspergillus is acquired primarily from an inanim-
ate reservoir, usually by the inhalation of small
airborne spores [3]. While nosocomial aspergil-
losis typically affects immunocompromised pa-
tients [4], post-operative aspergillosis occurs
mainly in immunocompetent patients, including
some patients who received corticosteroids tem-
porarily. This review is based on a search of the
world literature to identify cases of post-operative
aspergillosis occurring after surgical procedures
that were not secondary to disseminated infection




The Medline, LILACS and EMBASE databases were searched
and references from relevant articles were reviewed. Search
terms were ‘aspergillus’, ‘surgery’, ‘surgical site infections’,
‘cardiovascular surgical procedures’, ‘endocarditis’, ‘aortitis’,
‘mediastinitis’, ‘breast’, ‘laparotomy’, ‘arthroplasty’, ‘orthopae-
dic procedures’, ‘neurosurgery’, ‘transplantation’, ‘ophthal-
mologic surgical procedures’, ‘osteomyelitis’, ‘prosthesis’,
‘treatment’ and ‘prevention’. Conference abstracts were re-
viewedusing theAspergillusweb-site (http://www.aspergillus.
man.ac.uk). Apart from papers published in Japanese,
Russian, Czech or Polish, no language restrictionswere applied.
Non-surgical cases of primary cutaneous aspergillosis and
infections associated with intravascular devices were not con-
sidered for this review.
Deﬁnitions
Only cases of proven or probable infection were reviewed,
which required that all cases included were laboratory-
conﬁrmed by culture and ⁄or histology and ⁄ or microscopy.
These criteria were based on standard deﬁnitions for invasive
fungal infections in immunocompromised patients for clinical
research [5]. As the incubation period of aspergillosis is not
well-established, this review was not limited by the CDC
deﬁnitions of surgical site infection (i.e., infections occurring
within 30 days of a surgical procedure if no implant is left in
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place, or within 1 year if an implant is present) [6]. Wound
aspergillosis was deﬁned as infections involving only the skin
or subcutaneous tissue of the incision. Infections that involved
both superﬁcial and deep incision sites were classiﬁed as deep
surgical site infections, according to the site affected. For
classiﬁcation as a wound infection, in addition to a positive
culture of Aspergillus spp. taken directly from the wound, the
wound itself had to be non-healing following treatment with
standard antibiotics, with other pathogens absent or minimally
present.
LITERATURE REVIEW
From the initial search, c. 450 papers were exclud-
ed for several reasons, including cases of asper-
gillosis unrelated to surgery and disseminated
infections from pulmonary or other sources.
Other review articles with no new contributions
were also excluded. More than 500 patients with
post-operative aspergillosis were included in this
review, including cases following heart surgery
(188), neurosurgery (25), dental surgery (>100),
ophthalmological surgery (>90), orthopaedic sur-
gery (42), vascular prosthetic surgery (22),
abdominal surgery (10) and breast surgery (5).
Reports of wound infections (22), bronchial infec-
tions (30), mediastinitis (11) and pleural aspergil-
losis (1) were also included. Some cases were
reported more than once, i.e., [10] and [11]; [16]
and [129]. Table 1 summarises the key aspects of
Table 1. Summary of main clinical
presentations, treatment and pro-




Endocarditis ⁄ aortitis (n = 174) Marked male predominance (c. 70%)
Absence of immunosuppression for almost all patients
Aortic valve mostly involved (60.5%)
Median time from surgery to diagnosis = 2.7 months
Aspergillus fumigatus: aetiology in only 58.7% of cases
Low ante-mortem diagnosis (43.5%), usually following surgical
intervention
Blood cultures rarely positive (6.4%)
Propensity for late embolisation
Mortality >80% despite intervention (overall mortality 92.7%)
Neurosurgery infections (n = 25) Frequently associated with the use of steroids (52.0%)
All proven cases caused by A. fumigatus
Median time from surgery to diagnosis = 3 months
Higher ante-mortem diagnosis rate (68.0%) than for endocarditis
Mortality much lower than observed for immunocompromised
patients with aspergillosis disseminated to the central nervous
system
Dental surgery infections (n > 100) Many cases of sinus aspergillosis associated with endodontic
treatment
Obturating pastes within the maxillary antrum probably a risk-
factor
Wound infections (n = 22) Most patients immunosuppressed
Median time from surgery to diagnosis = 17 days
A. ﬂavus accounts for 41.2% of cases conﬁrmed by culture
Risk of dissemination
Ophthalmological surgery infections (n > 90) Usually presents as keratitis
Diagnosis requires sampling at the site of infection
Vascular prosthesis infections (n = 22) Almost all patients are male and immunocompetent
Median time from surgery to diagnosis = 8 months
Clinical picture indistinguishable from Staphylococcus epidermidis
infections
Usually occurs close to suture lines of previous aortotomy
High incidence of embolisation to vertebral disks
Other cases (n = 113) Frequent association with prosthesis insertion
Treatment The optimal treatment has not been speciﬁcally studied
Survival seemingly dependent on excision of the infected tissue; in
cases involving a prosthesis, the new prosthesis should be placed
in a non-infected ﬁeld
Concomitant use of a systemic antifungal agent is also crucial.
Although there are no data favouring any one antifungal drug, the
response rates to voriconazole in immunocompromised patients
were superior to those in response to amphotericin B. Caspofungin
and other echinocandins may also be useful. Longer-term oral
extension with itraconazole or voriconazole is appropriate for
some patients
The optimal duration of therapy is unknown and is likely to differ
between patients, but once as much infected tissue as possible has
been removed and any immunocompromising factors, such as
corticosteroid therapy, are minimised, treatment for 3 months
beyond the last evidence of active disease may be appropriate
Prevention Requires special care with the ventilation system in the operating
theatre
Proper disinfection and storage of surgical materials
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post-operative aspergillosis following different
surgical procedures.
The ﬁrst case reported in the literature
In 1933, a female aged 14 years underwent sur-
gery for an abdominal tumour [7]. After 16 days,
the dressing was removed and an ulcer was
observed. There were no systemic manifestations
of the infection, but Aspergillus niger grew in the
surgical dressings, which were covered with a
‘dark powder’. It was speculated that contamin-
ation may have occurred in the operating room,
and the authors commented on two previous
similar cases of wound aspergillosis in the same
medical centre, each exhibiting similar pustula-
tion conﬁned to the area of the gauze dressing,
and with rapid healing after local treatment with
iodine and alcohol.
Endocarditis, aortitis and other presentations of
aspergillosis following cardiac surgery
Table S1 (see Supplementary material) summa-
rises some clinical details for 124 patients with
Aspergillus endocarditis or aortitis following heart
surgery [4,8–91]. The median age of these patients
was 43.5 (range 0.8–71) years. Most of the surgical
procedures involved the aortic (60.5%) or mitral
(30.6%) valve, and no particular prosthesis was
associated with the infection. Male patients pre-
dominated (69.9%), which may be related to the
higher prevalence of coronary and aortic valve
surgery in males than in females. The incubation
period was variable, with a mean time from
surgery to the diagnosis (often following autopsy)
of 2.7 (range <1 to >12) months. Two cases [43,88]
had possible incubation periods of several years;
silent Aspergillus fungaemia with late endocarditis
is possible in such cases, although there is no
direct evidence for such a diagnosis. Forty addi-
tional cases were cited in other studies, but
without detailed information [92–111], and at
least ten additional cases were reported in lan-
guages other than English [112–120].
Notably, almost none of the patients were
immunosuppressed, and there was no evidence
of bronchopulmonary aspergillosis. The post-
operative course of these patients was usually
consistent with culture-negative endocarditis.
Unusual presentations of aspergillosis following
heart surgery included osteochondritis and ⁄ or
osteomyelitis after sternotomy [78,121–125], and
saphenous vein thrombosis [126] or rupture [127]
after coronary by-pass surgery.
Aspergillus fumigatus was the aetiological
agent in only 58.7% of cases conﬁrmed by
culture. Other important species were Aspergillus
terreus (12.5%), which is resistant to amphoter-
icin B, A. niger (11.2%) and Aspergillus ﬂavus
(11.2%). Most reports associated the infection
with contaminated grafts, contaminated sutures
or intra-operative dispersion of spores. The
prevention of such infections will be considered
below.
The difﬁculty in establishing the diagnosis of
Aspergillus endocarditis is well-known, since the
fungus is isolated infrequently from blood
cultures. Only eight cases of post-operative asper-
gillosis associated with a positive blood cul-
ture (6.4% of cases) were found in the literature
[11,12,14,36,38,46,61,87]. Pre-autopsy diagnosis
was made in only 43.5% of cases. In the vast
majority of cases, surgical intervention was cru-
cial in obtaining a deﬁnitive diagnosis, often
following examination of either the valve
(23.4%) or emboli to large peripheral arteries
(16.9%). Unfortunately, some surgical specimens
were not sent for culture. The diagnosis of
Aspergillus aortitis is also made more difﬁcult
because of the localisation of the infection and the
absence of endocarditis vegetation; this condition
is therefore often undetected by both trans-thor-
acic and trans-oesophageal echocardiography.
Computed tomography scan, magnetic resonance
imaging and angiography might be more helpful
for the diagnosis of such cases.
The overall mortality rate was 92.7%. In addi-
tion, 83.0% of patients who had an ante-mortem
diagnosis died, and a high mortality rate (80.9%)
existed even among patients treated with a
surgical intervention in the affected valve. This
might be related to a delayed diagnosis, which
gives the fungus the opportunity to establish large
vegetations, to cause extensive local necrosis, and
eventually to embolise to large arteries. Many of
the patients who underwent valve replacement
died during surgery or a few days later. These
results indicate an unequivocal need for better
diagnostic methods for this condition. At the
present time, the role of antibody tests and
molecular tests of blood samples has not been
properly investigated. In one report, a false-
negative galactomannan result occurred for a
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patient with non-surgical Aspergillus endocarditis,
despite a positive blood culture for A. fumigatus
[128].
Wound infections
For patients with post-operative wound infection
caused by Aspergillus spp., the interval between
surgery and infection is measured in days, rather
than the months required for endocarditis (Table
S2, see Supplementary material) [5,87,129–143] In
addition, many patients with wound aspergillosis
were immunosuppressed, with half of the cases
occurring in solid-organ transplant recipients. As
this condition can progress to profound or dis-
seminated infection, all patients need to be treated
aggressively with combined medical and surgical
therapy. A. ﬂavus is a particularly important
species in wound aspergillosis, accounting for
41.2% of cases conﬁrmed by culture.
Chronic lung disease was the only independent
risk-factor for A. fumigatus sternal wound infec-
tion after open-heart surgery in a case-control
study [144]. A. fumigatus was grown simulta-
neously from the bronchial washings of one
patient, suggesting that colonised patients may
be at increased risk for these infections. In another
study, a cluster of four cases of surgical and burn
wound aspergillosis was associated with the
outside packages of dressing supplies, which
had become contaminated during hospital con-
struction work [145]. This resulted in patients
with large exposed vulnerable surface areas being
inoculated directly with Aspergillus spores. When
outbreaks of cutaneous aspergillosis occur,
wound dressing and tape should be cultured
[146,147]. Cases of A. ﬂavus sternal wound infec-
tion coinciding with hospital renovation activities
have also been reported [148].
Neurosurgery
Involvement of the central nervous system in
aspergillosis may occur via haematogenous dis-
semination (usually from the lungs), or by direct
extension from nasal or paranasal foci [149]. Table
S3 (see Supplementary material) summarises the
published literature concerning aspergillosis fol-
lowing neurosurgical procedures [150–168]. In
contrast to Aspergillus endocarditis, male patients
were not over-represented in neurosurgical infec-
tions (44.0%). Previous treatment with cortico-
steroids was mentioned in 52.0% of the reports,
including patients receiving regimens of pulse
therapy, high-dose regimens for periods of weeks
to months, and even physiological steroid
replacement therapy. The median time from
surgery to diagnosis was 3 (range <1 to >12)
months. All proven cases were caused by A. fu-
migatus. As shown in Table S3, different presen-
tations of the infection can occur, including
meningitis, central nervous system abscesses,
mycotic aneurysms and cerebral infarction. Many
cases were associated with Aspergillus contamin-
ation from paranasal sinuses, particularly follow-
ing trans-sphenoidal surgery.
An ante-mortem diagnosis was performed in
68% of cases, which was a proportion consider-
ably higher than that for cases of Aspergillus
endocarditis. Most of these cases were diagnosed
after abscess drainage (36%), and 20% of patients
had a cerebrospinal ﬂuid culture positive for
Aspergillus. In some cases, a culture positive for
Aspergillus was considered to be contamination,
which was associated with delayed treatment,
sometimes with a fatal outcome. All patients who
survived received combined aggressive clinical
and surgical therapy. The overall mortality rate
was 68.0%, which is surprisingly low in compar-
ison with mortality rates of >90% for immuno-
suppressed patients with disseminated
aspergillosis involving the central nervous sys-
tem. This may reﬂect an earlier diagnosis, facili-
tated by imaging techniques, in association with
aggressive neurosurgical intervention. Further-
more, dexamethasone therapy could be with-
drawn for many of these patients, unlike the
situation for patients with more permanent
immunosuppression.
Dental surgery
A number of studies have reported a connection
between endodontic treatment and non-invasive
sinus aspergillosis, mainly in the presence of
obturating pastes within the maxillary antrum
[169–183]. Experiments with fungal cultures have
revealed accelerated growth of Aspergillus spp. in
the presence of zinc oxide in the culture medium
[182]. With respect to treatment, it is necessary to
remove surgically the fungal masses in the
sinuses, and especially all zinc-containing radio-
paque material, and to ensure establishment of
adequate sinus drainage and aeration [178,181].
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Systemic antifungal agents are generally not
recommended to complement the surgical proce-
dure unless there are signs of local invasion [181].
Ophthalmological surgery
Ocular aspergillosis usually presents as keratitis,
and rarely as endophthalmitis [92,184–187]. Post-
operative infections have been described follow-
ing penetrating keratoplasty [188–190], radial
keratotomy [191–194], excimer laser photo-
refractive keratectomy [195], laser-assisted in-situ
keratomileusis [196–199], pterygium excision
[200,201], hydroxyapatite orbital implant surgery
[202], cataract surgery [179,184,203–212], scleral
buckling procedures [213,214], sutureless surgery
[215,216] and trabeculectomy [204,217]. Sampling
at the site of infection provides the best chance for
obtaining a positive culture [196,218–220]. While
some cases of Aspergillus endophthalmitis and
keratitis have been associated with hospital con-
struction [209,221], others have been linked to
contaminated irrigating ﬂuids used during sur-
gery [208]. Many cases of Aspergillus keratitis and
scleritis following non-surgical corneal trauma
have also been reported [209,222–248], frequently
in farmers. The efﬁcacy of the antifungal therapy
depends to a great extent on the ability of the
compound used to penetrate the eye [219,249].
Orthopaedic surgery
A male aged 64 years underwent hip replacement
surgery and was admitted after a 9-year interval
because of progressive hip pain [250]. A. niger
grew from aspirated hip ﬂuid, and the patient
was treated with amphotericin B and prosthesis
replacement. Two cases of aspergillosis following
laminectomy were also reported in the same
publication. In another report, A. fumigatus
spondylodiskitis occurred 2.5 months after lum-
bar disk surgery, and the patient was treated with
itraconazole in combination with surgical debri-
dement [251]. Other cases following lumbar sur-
gery have also been reported [252–254].
In a prospective study of 658 consecutive total
hip arthroplasty procedures in which cultures
were taken at surgery, Aspergillus was recovered
in 4.1% of cases, and Aspergillus was also culti-
vated from the air in the operating theatre [255].
In another report, a male aged 22 years developed
Aspergillus osteomyelitis after a closed fracture of
the femur and subsequent surgery [256]. Another
male, aged 16 years, developed infection with
A. ﬂavus following surgery for a fracture of the
femur. The infection was associated with pressure
and necrosis caused by casts [257]. The ﬁrst case
of aspergillosis complicating total knee arthropl-
asty was described in a male aged 80 years who
was receiving chronic corticosteroid therapy
[258]. This patient presented with a popliteal cyst
27 months after surgery, and was cured with a 12-
week course of amphotericin B in combination
with surgical debridement and prosthesis re-
moval. Other similar cases have been described
in the literature [259,260].
Bronchopulmonary surgery
Bronchial stump aspergillosis, i.e., Aspergillus
infection of bronchial granulation tissue sur-
rounding endobronchial sutures after pulmonary
resection, is a rare clinical presentation of Asperg-
illus infection [261–267]. This condition is more
common when silk thread is used as the suture
material rather than stainless steel [268,269], and
should be considered in the differential diagnosis
of haemoptysis, coughing and dyspnoea occur-
ring up to several years after lung surgery,
although asymptomatic presentation is also poss-
ible [262–264,269]. Aspergillus suture granuloma
may simulate recurrent neoplastic disease in
patients undergoing resection for pulmonary
cancer [270]. Although no comparative studies
exist, removal of the silk suture is probably the
key therapeutic intervention for this condition.
An association between the presence of sa-
prophytic fungi in the bronchial anastomosis and
the occurrence of serious airway complications
following lung transplantation has been proposed
[271]. The ischaemic and necrotic airway debris at
the bronchial anastomosis provides a fertile envi-
ronment for Aspergillus proliferation. Several
reports have also described an increased risk of
complications as a consequence of post-transplan-
tation saprophytic Aspergillus disease [272–275].
The source of these infections has not been well-
studied, but may be related to either colonisation
of the diseased or transplanted lungs, or to direct
perioperative acquisition.
Pleural aspergillosis has been reported as an
iatrogenic complication of lung adenocarcinoma
resection [276]. A 14-day course of intravenous
caspofungin failed to sterilise the cavity, and
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the patient was treated with a combination of
intra-pleural and systemic amphotericin B lipid
complex.
Infection of vascular prosthesis
Glotzbach [277] seems to have been the ﬁrst to
describe Aspergillus infection of a vascular pros-
thesis in 1982, and this was followed by the report
of an immunocompetent patient, aged 73 years,
with aortic pseudoaneurysm and contiguous ver-
tebral osteomyelitis, who was treated with graft
resection and amphotericin B [278]; as in the
previous case [277], this patient presented with
back pain c. 2 years after surgery. In a study of 14
cases of fungal graft infections [279], only four
were caused by Aspergillus spp.
Aspergillus graft infections usually occur on the
suture line of a previous aortotomy [280]. Deﬁn-
itive diagnostic procedures for these patients
generally involve culture of the excised aortic
graft or the peripheral embolus, and biopsy of the
contiguously affected vertebral disk space
[277,281–284]. As with endocarditis, almost all
cases have involved immunocompetent males
[277,278,281–290]. The median time from the
placement of the graft to diagnosis is 8 months,
which is a longer period than that for Candida
graft infections (usually <6 weeks) [279]. Fever is
absent in about one-half of the cases. One report
associated in-situ replacements or treatment with-
out excision of the infected graft with recurrence
and death in all cases, whereas all patients who
underwent an extra-anatomical by-pass through a
clean ﬁeld survived [279]. No difference seems to
exist between the clinical presentations of fungal
and bacterial vascular prosthesis infections,
particularly when Staphylococcus epidermidis is
involved [291].
Abdominal surgery
Multiple abdominal visceral infection by A. fumig-
atus occurred in a female aged 37 years after
laparostomy for Crohn’s disease [292]. The patient
was treated successfully with a 4-week course of
amphotericin B. Sampling of air from the patient’s
environment yielded one isolate of A. fumigatus
that matched the patient’s isolates, suggesting that
this patient acquired the infection from air in the
intensive care unit. Peritoneal aspergillosis has also
been reported following laparotomy in non-trans-
plant patients [4,293,294], and Aspergillus cholan-
gitis complicating portoenterostomy for a biliary
atresia has also been reported [295]. A case of
A. ﬂavus renal pelvis infection, following a pyelo-
lithotomy, has been described, with Aspergillus
around the suture material [296]. Post-operative
cases of wound infection [87,138,139,141–143,297],
peritonitis [297,298] and renal allograft infection
[299] have also been described following solid-
organ transplantation.Althoughnot always appar-
ent, it is possible that some of these patients had
occult foci from which the Aspergillus may have
disseminated [299–325].
Mediastinitis
Aspergillus mediastinitis in surgical patients has
been described in association with deep sternal
wound infection [4,123,125,326], heart transplan-
tation [326–329], aortitis [4,46] and patch infection
after repaired tetralogy of Fallot [113]. Two immu-
nocompetent patients were also affected during an
outbreak of aspergillosis related to a contaminated
air-handling system [4]. The importance of consid-
ering aspergillosis in the differential diagnosis of
slowly progressive, but destructive, wound infec-
tions and culture-negative mediastinitis after car-
diac surgery has been emphasised.
Breast surgery
Fungal infections of the soft tissue have been
reported in association with prosthetic breast
implants [330–333]. A healthy female, aged
39 years, with bilateral inﬂatable silicone breast
implants was colonised by A. niger as a possible
consequence of massive contamination during
surgery [331]. A. ﬂavus was also cultured from a
saline-ﬁlled implant removed from a healthy
young patient who developed unilateral breast
inﬂammation 4 years after surgery [332]. It has
been shown that fungi can grow and reproduce in
a saline-only environment, and that their survival
periods differ among species [334–336]. Colonisa-
tion of a tissue expander by A. niger, resulting in
mechanical obstruction of the device, has also
been described [337].
Linking the infection with the operating theatre
Many studies have associated the occurrence of
post-operative aspergillosis with the dissemin-
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ation of Aspergillus spores in the operating theatre.
In one investigation, pigeonexcreta andmoss in the
immediate vicinity of the ventilator intake port
were found to harbour large numbers ofAspergillus
spores [14]. Similarly,Aspergilluswas isolated from
all areas of the theatre suite in another study [38],
except in a room ﬁtted with laminar airﬂow. Air-
conditioner cooling coils and pigeon droppings on
the ledges outside the suite were found to harbour
large numbers of Aspergillus spores.
Environmental studies conducted during an
outbreak of A. ﬂavus sternal infection [123] re-
vealed massive fungal contamination in some
areas of the surgical ward [338]. When isolates
from patients and from the environment were
typed, the same genotype was detected, implica-
ting a single clonal source for the environmental
contamination and intra-operative acquisition of
A. ﬂavus. Diaz-Guerra et al. [339] reported the
simultaneous isolation of an A. ﬂavus isolate from
the aortic prosthesis of a heart surgery patient and
two isolates from a dual-reservoir cooler–heater
used in the operating theatre where this patient
received surgery. Genetic typing of these isolates
by random ampliﬁed polymorphic DNA analysis
revealed identical genotypes, indicating the no-
socomial origin of the strain. Similar results were
reported in another investigation [51], and during
an epidemiological investigation of cases of As-
pergillus aortitis following cardiac surgery [46],
high concentrations of A. fumigatus were found in
the ventilation system and on the ﬂoor of the
surgical suite.
Prevention
Most modern operating theatres have conven-
tional ventilation and ﬁlters that remove air-
borne particles ‡5 lm [340]. However, these
ﬁlters are not sufﬁcient to remove Aspergillus
spores (2.5–3.0 lm in size). Laminar airﬂow
systems and HEPA ﬁltration will remove air-
borne particles ‡0.3 lm with 99.97% efﬁciency.
These systems are generally used in orthopaedic
and other implant surgery [341], as well as in
protective environments for high-risk patients
[342–347]. Theoretically, these systems are more
effective in preventing post-operative aspergil-
losis, but data demonstrating a survival beneﬁt
for patients are lacking [348,349]. Furthermore,
these systems are limited by the expense of
construction and maintenance, and by a lack
of consensus concerning the level of airborne
conidia at which the risk can be numerically
deﬁned for aspergillosis [340].
Since outbreaks of post-operative aspergillosis
have occurred occasionally in units with HEPA
ﬁlters [78], periodic maintenance of ventilation
systems seems to be warranted [38,346,350]. Some
of these incidents were caused by contamination
of insulation in variable airﬂow volume units that
had deteriorated after becoming wet. As fungi can
inhabit water distribution systems and may cause
nosocomial infection, tap water should not be
used on surgical wounds. However, larger con-
trolled studies are needed to determine the role of
water in the transmission of aspergillosis [2,3].
The patients may also be their own source of
infection in some circumstances [159], as has been
demonstrated for staphylococcal infections. Pre-
vention of post-operative aspergillosis requires
proper disinfection techniques, as well as appro-
priate storage of surgical materials. A single
proven post-operative case of aspergillosis should
be sufﬁcient to initiate epidemiological investiga-
tions.
CONCLUSIONS
Post-operative aspergillosis seems to be an under-
appreciated problem, particularly when com-
pared with other extra-pulmonary manifestations
of invasive aspergillosis. Mortality is high for
non-cutaneous infections. Several organs and
surgical procedures may be involved, depending
on the surgery performed. These infections are
usually indolent, in some cases occurring several
months after surgery. In most patients, the source
of the spores seems to have originated from the
air during surgery, but contamination from para-
nasal sinuses, bronchopulmonary lesions, haema-
togenous dissemination and contaminated grafts
is also possible. In order to improve the outcome,
better diagnostic methods are needed. Infected
patients should receive aggressive combined
medical and surgical therapy. Prevention of these
infections should include special care of the
ventilation system in the operating theatre and
adequate sterilisation techniques.
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SUPPLEMENTARY MATERIAL
The following supplementary material is avail-
able for this article online at http://www.
blackwell-synergy.com:
Table S1. Case reports of post-operative endo-
carditis ⁄ aortitis caused by Aspergillus spp.
Table S2. Case reports of wound infections with
Aspergillus spp. following surgical procedures.
Table S3. Case reports of central nervous system
infections with Aspergillus spp. following neuro-
surgical procedures.
REFERENCES
1. Walsh TJ, Dixon DM. Nosocomial aspergillosis: envi-
ronmental microbiology, hospital epidemiology, diagno-
sis and treatment. Eur J Epidemiol 1989; 5: 131–142.
2. Anaissie EJ, Stratton SL, Dignani MC et al. Pathogenic
Aspergillus species recovered from a hospital water sys-
tem: a 3-year prospective study. Clin Infect Dis 2002; 34:
780–789.
3. Soubani AO, Chandrasekar PH. The clinical spectrum of
pulmonary aspergillosis. Chest 2002; 121: 1988–1999.
4. Lutz BD, Jin J, Rinaldi MG, Wickes BL, Huycke MM.
Outbreak of invasive Aspergillus infection in surgical
patients, associated with a contaminated air-handling
system. Clin Infect Dis 2003; 37: 786–793.
5. Ascioglu S, Rex JH, de Pauw B et al. Deﬁning opportun-
istic invasive fungal infections in immunocompromised
patients with cancer and hematopoietic stem cell trans-
plants: an international consensus. Clin Infect Dis 2002; 34:
7–14.
6. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes
JM. CDC deﬁnitions for nosocomial infections. In:
Olmsted RN, ed., APIC infection control and applied
epidemiology: principles and practice. St Louis: Mosby,
1996; A1–A20.
7. Frank L, Alton OM. Aspergillosis: a case of post-operative
skin infection. JAMA 1933; 100: 2007–2008.
8. Amoury RA, Bowman FO, Malm JR. Endocarditis asso-
ciated with intracardiac prostheses. Diagnosis, manage-
ment, and prophylaxis. J Thorac Cardiovasc Surg 1966; 51:
36–48.
9. Leffert RL, Hackett RL. Aspergillus aortitis following
replacement of aortic valve. J Thorac Cardiovasc Surg 1967;
53: 866–874.
10. Jones T, Meshel L, Rubin IL. Aspergillus endocarditis
superimposed on aortic valve prosthesis. NY State J Med
1969; 69: 1923–1928.
11. Hairston P, Lee WH. Mycotic (fungal) endocarditis after
cardiovascular surgery. Am Surg 1969; 35: 135–143.
12. Hairston P, Lee WH. Management of infected prosthetic
heart valves. Ann Thorac Surg 1970; 9: 229–237.
13. Aslam PA, Gourley R, Eastridge CE, Pate JW. Aspergillus
endocarditis after aortic valve replacement. Int Surg 1970;
53: 91–96.
14. Gage AA, Dean DC, Schimert G, Minsley N. Aspergillus
infection after cardiac surgery. Arch Surg 1970; 101: 384–
387.
15. Chaudhuri MR. Fungal endocarditis after valve replace-
ment. J Thorac Cardiovasc Surg 1970; 60: 207–214.
16. Ostermiller WE, Dye WS, Weinberg M. Fungal endocar-
ditis following cardiovascular surgery. J Thorac Cardiovasc
Surg 1971; 61: 670–675.
17. Lawrence T, Shockman AT, MacVaugh H. Aspergillus
infection of prosthetic aortic valves. Chest 1971; 60: 406–
414.
18. Carrizosa J, Levison ME, Lawrence T, Kaye D. Cure of
Aspergillus ustus endocarditis on a prosthetic valve. Arch
Intern Med 1974; 133: 486–490.
19. Doshi R. Aspergillus fumigatus endocarditis of an aortic
homograft with aneurysm of the ascending aorta. J Pathol
1971; 103: 263–265.
20. Harthorne JW, Castleman B. Case records of the Massa-
chusetts General Hospital. Weekly clinicopathological
exercises. Case 24-1973.N Engl J Med 1973; 288: 1290–1296.
21. Dayal Y, Weindling HK, Price DL. Cerebral infarction
due to fungal embolus. A complication of Aspergillus
infection on an aortic valve prosthesis. Neurology 1974; 24:
76–79.
22. Foxworthy D, Gunnar R. Complications of aortic valve
replacement. Postgrad Med 1974; 56: 146–151.
23. Rubinstein E, Noriega ER, Simberkoff MS, Holzman R,
Rahal JJ. Fungal endocarditis: analysis of 24 cases and
review of the literature.Medicine (Baltimore) 1975; 54: 331–
334.
24. Utley JR, Mills J, Roe BB. The role of valve replacement in
the treatment of fungal endocarditis. J Thorac Cardiovasc
Surg 1975; 69: 255–258.
25. Wheeler EO, Robboy SJ. Case records of the Massachu-
setts General Hospital. Weekly clinicopathological exer-
cises. Case 39-1976. N Engl J Med 1976; 295: 718–724.
26. Petheram IS, Seal RM. Aspergillus prosthetic valve endo-
carditis. Thorax 1976; 31: 380–390.
27. Irvin RG, Sade RM. Endocarditis and musculoskeletal
manifestations. Ann Intern Med 1978; 88: 578.
28. Drexler L, Rytel M, Keelan M, Bonchek LI, Olinger GN.
Aspergillus terreus infective endocarditis on a porcine
heterograft valve. J Thorac Cardiovasc Surg 1980; 79: 269–
274.
29. Middleton J, Chmel H, Tecson F, Sarkaria JS, Neville WE.
Aortotomy site infections: case presentation and review
of the literature. Am J Med Sci 1980; 279: 105–109.
30. Vo NM, Russell JC, Becker DR. Mycotic emboli of the
peripheral vessels: analysis of forty-four cases. Surgery
1981; 90: 541–545.
31. Rozo L, Cesbron JP, de Lajartre AY, Marjolet M, Dupon
H, Nicolas G. Aspergillus endocarditis following valve
replacement. Apropos of 5 cases. Arch Mal Coeur Vaiss
1983; 76: 822–830.
32. Moore RS, Hasleton PS, Lawson RA, Stanbridge TN.
Aspergillus niger endocarditis complicating aortic tissue
valve replacement. Thorax 1984; 39: 76–77.
33. Farina C, Filice C, Carnevale G, Maserati R, Alberici F.
Aspergillus endocarditis: a clinical report. G Malatt Infett
Parassitar 1985; 37: 205–208.
34. John V, Shuhaiber HJ, Chugh TD, Ghosh DK. Aspergillus
fumigatus endocarditis on a Carpentier–Edwards xeno-
graft. J Kuwait Med Assoc 1987; 21: 210–213.
35. Corrigan C, Horner SM. Aspergillus endocarditis in
association with a false aortic aneurysm. Clin Cardiol
1988; 11: 430–432.
Pasqualotto and Denning Post-operative aspergillosis 1067
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 1060–1076
36. Verghese S, Mullasari A, Padmaja P, Sudha P, Sapna MC,
Cherian KM. Fungal endocarditis following cardiac
surgery. Ind Heart J 1998; 50: 418–422.
37. Vivas C. Endocarditis caused by Aspergillus niger: case
report. Clin Infect Dis 1998; 27: 1322–1323.
38. Mehta G. Aspergillus endocarditis after open heart sur-
gery: an epidemiological investigation. J Hosp Infect 1990;
15: 245–253.
39. Jenckes GA. Aspergillus aortitis. J Thorac Cardiovasc Surg
1990; 99: 375–376.
40. Ledesma D, William HP. Septic (Aspergillus) embolus.
N Engl J Med 2000; 342: 1015.
41. Kocazeybek B, Sonmez B, Sarman K et al. Diagnosis at
ﬁrst glance: hairy black colonies in resected prosthetic
aortic valve. Clin Microbiol Infect 2000; 6: 617–618.
42. Galrinho A, Tavares J, Caria R, Veiga C. Fungal endo-
carditis with atypical localization in patients with aortic
prosthesis. Rev Port Cardiol 2000; 19: 1045–1047.
43. Plaza Martı´nez A, Dı´az Lo´pez M, Riera Va´zquez R et al.
Bilateral popliteal embolism secondary to the fungal
infection of the scar tissue resulting from aortotomy.
Angiologia 2002; 54: 455–459.
44. Ramos AO, Medeiros AR, Paulista PP, Abboud CS, Me-
neghelo ZM. Aspergillus infection in the ascending aorta
of a patient with aortic and mitral valve prostheses. Arq
Bras Cardiol 2003; 81: 419–420.
45. Lo´pez-Go´mez M, Lo´pez-Ruz MA, Jime´nez-Alonso JF.
Mycotic aneurysm of the superior mesenteric artery and
intestinal infarction due to Aspergillus. Enferm Infecc
Microbiol Clin 2003; 21: 530.
46. Sanchez-Recalde A, Mate I, Merino JL, Simon RS, Sobrino
JA. Aspergillus aortitis after cardiac surgery. J Am Coll
Cardiol 2003; 41: 152–156.
47. El-Hamamsy I, Du¨rrleman N, Stevens LM et al. A cluster
of cases of Aspergillus endocarditis after cardiac surgery.
Ann Thorac Surg 2004; 77: 2184–2186.
48. Reis LJ, Barton TD, Pochettino A et al. Successful treat-
ment of Aspergillus prosthetic valve endocarditis with
oral voriconazole. Clin Infect Dis 2005; 41: 752–753.
49. Lo´nyai T, Fehe´r C, Tima´r K. Aspergillus endocarditis fol-
lowing aortic valve replacement. Acta Chir Acad Sci Hung
1973; 14: 43–51.
50. Villate JI, Aldamiz-Echevarria G, Gaztelurrutia L, Bar-
renechea JI, Gonzalez de Zarate P. Cardiac aspergillosis.
J Thorac Cardiovasc Surg 2000; 119: 403–404.
51. Veinot JP, Lorimer JW, Walley VM, Turek M, Saginur R,
Rubens F. Aortitis with multiple aneurysms mimicking
infective endocarditis. Can J Cardiol 1999; 15: 105–109.
52. Malivi TA, Webb HM, Dixon CD, Boone JA. Systemic
aspergillosis caused by Aspergillus niger after open-heart
surgery. JAMA 1968; 203: 520–522.
53. Anonymous. A case of fungal endocarditis. BMJ 1969; 3:
765–779.
54. Malcolm AD, Bakerspigel A, Enriquez AA. Aspergillus
ﬂavus endaortitis following aortic valvotomy. Thorax
1971; 26: 435–442.
55. Horten BC, Abbott GF, Porro RS. Fungal aneurysms of
intracranial vessels. Arch Neurol 1976; 33: 577–579.
56. Kleiman MB. Echocardiography in Aspergillus endocar-
ditis. Pediatrics 1982; 69: 252–253.
57. Koshi G, Cherian KM. Aspergillus terreus, an uncommon
fungus causing aortic root abscess and pseudoaneurysm.
Ind Heart J 1995; 47: 265–267.
58. Hadorn W. Aortic rupture caused by Aspergillus infection
following operation in aortic stenosis. Endaortitis
polyposa mycotica. Schweiz Med Wochenschr 1960; 90: 929–
934.
59. Bortolotti U, Thiene G, Milano A, Panizzon G, Valente M,
Gallucci V. Pathological study of infective endocarditis
on Hancock porcine bioprostheses. J Thorac Cardiovasc
Surg 1981; 81: 934–942.
60. Laham MN, Carpenter JL. Aspergillus terreus, a pathogen
capable of causing infective endocarditis, pulmonary
mycetoma, and allergic bronchopulmonary aspergillosis.
Am Rev Respir Dis 1982; 125: 769–772.
61. Newman WH, Cordell RA. Aspergillus endocarditis after
open-heart surgery. Report of a case and review of lit-
erature. J Thorac Cardiovasc Surg 1964; 48: 652–660.
62. Darrell RW. Endogenous Aspergillus uveitis following
heart surgery. Arch Ophthalmol 1967; 78: 354–357.
63. Morea M, Girelli L, Benintendi V, Scaravilli F. Aspergillus
endocarditis following cardiosurgical operation. Chir Ital
1967; 19 (suppl 2): 173–185.
64. Khan TH, Kane EG, Dean DC. Aspergillus endocarditis of
mitral prosthesis. Am J Cardiol 1968; 22: 277–280.
65. Chelloul P, Adotti F, Caulin C, Manicacci M, Cornu P,
Dentan M. Cardio-aortic aspergillosis. Sem Hop 1971; 47:
825–831.
66. Schelbert HR, Muller OF. Detection of fungal vegetations
involving a Starr–Edwards mitral prosthesis by means of
ultrasound. Vasc Surg 1972; 6: 20–25.
67. Harford CG. Postoperative fungal endocarditis. Funge-
mia, embolism, and therapy. Arch Intern Med 1974; 134:
116–120.
68. Kammer RB, Utz JP. Aspergillus species endocarditis. The
new face of a not so rare disease. Am J Med 1974; 56: 506–
521.
69. Gallego Page JC, Marquez Montes J, Ortigosa Aso FJ et al.
Endocarditis by Aspergillus: a case report. Clin Cardiovasc
1998; 16: 12–14.
70. Chow WH, Ng TH, Chow TC, Tai YT, Cheung KL. Free-
ﬂoating Aspergillus vegetation in left atrium: identiﬁca-
tion by two-dimensional echocardiography. J Clin Ultra-
sound 1991; 19: 315–317.
71. Verghese S, Maria CF, Mullaseri AS, Asha M, Padmaja P,
Padhye AA. Aspergillus endocarditis presenting as
femoral artery embolism. Mycosis 2004; 47: 252–256.
72. Tomaru A, Horiguchi M. Complications of valvular
surgery—5 case reports with special reference to the
conduction system. Jpn Circ J 1975; 39: 1225–1240.
73. Mershon JC, Samuelson DR, Layman TE. Left ventricular
‘ﬁbrous body’ aneurysm caused by aspergillus endocar-
ditis. Am J Cardiol 1968; 22: 281–285.
74. Wagner DK, Werner PH, Bonchek LI, Shimshak T, Rytel
MW. Successful treatment of post-mitral valve annu-
loplasty Aspergillus ﬂavus endocarditis. Am J Med 1985; 79:
777–780.
75. Robbins JA, Mohanty PK, Mohanty LB. Aortic aspergil-
loma resulting in supraventricular aortic stenosis after
aortocoronary bypass surgery. Am Heart J 1983; 106: 163–
166.
76. Gray R, Kaplan L, Matloff J et al. Aortic pseudo-aneur-
ysm with Aspergillus aortitis: an unusual complication of
coronary bypass surgery. Chest 1986; 89: 306–308.
77. Opal SM, Reller LB, Harrington G, Cannady P. Aspergillus
clavatus endocarditis involving a normal aortic valve
1068 Clinical Microbiology and Infection, Volume 12 Number 11, November 2006
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 1060–1076
following coronary artery surgery. Rev Infect Dis 1986; 8:
781–785.
78. Weber SF, Washburn RG. Invasive Aspergillus infections
complicating coronary artery bypass grafting. South Med J
1990; 83: 584–588.
79. Kaneda T, Iemura J, Oka H et al. Treatment of deep
infection following thoracic aorta graft replacement
without graft removal. Ann Vasc Surg 2001; 15: 430–434.
80. Choyke PL, Edmonds PR, Markowitz RI, Kleinman CS,
Laks H. Mycotic pulmonary artery aneurysm: complica-
tion of Aspergillus endocarditis. Am J Roentgenol 1982; 138:
1172–1175.
81. Shrivastava S, Radhakrishnan S. Infective endocarditis
following patch closure of ventricular septal defect: a
cross-sectional Doppler echocardiographic study. Int J
Cardiol 1989; 25: 27–31.
82. Navabi MA, Ajami H, Amirghofran A, Peyravian F. As-
pergillus endocarditis: rare but serious Aspergillus ball
obstructing the pulmonary artery. Eur J Cardiothorac Surg
1998; 14: 530–532.
83. Barst RJ, Prince AS, Neu HC. Aspergillus endocarditis in
children: case report and review of the literature. Pediat-
rics 1981; 68: 73–78.
84. Shoar MG, Zomorodian K, Saadat F, Hashemi MJ, Tar-
azoei B. Fatal endocarditis due to Aspergillus ﬂavus in
Iran. J Pak Med Assoc 2004; 54: 485–486.
85. Doughten RM, Pearson HA. Disseminated intravascular
coagulation associated with Aspergillus endocarditis.
Fatal outcome following heparin therapy. J Pediatr 1968;
73: 576–582.
86. Hosking MC, MacDonald NE, Cornel G. Liposomal
amphotericin B for postoperative Aspergillus fumigatus
endocarditis. Ann Thorac Surg 1995; 59: 1015–1017.
87. Khan ZU, Chugh TD. Invasive fungal infections in Ku-
wait: a retrospective study. Ind J Chest Dis Allied Sci 2000;
42: 279–287.
88. Fujioka S, Karashima K, Inoue A, Takami H, Nishikawa
N, Saito Y. Case of infectious endocarditis predicted by
orbital color Doppler imaging. Jpn J Ophthalmol 2005; 49:
46–48.
89. Thamlikitkul V, Prachuabmoh K, Sukroongreung S,
Danchaivijitr S. Aspergillus terreus endocarditis—a case
report. J Med Assoc Thai 1983; 66: 723–726.
90. Barbone A, Pini D, Grossi P et al. Aspergillus left ventric-
ular assist device endocarditis. Ital Heart J 2004; 5: 876–
880.
91. Escribano Subias P, Lopez Rios F, Delgado Jimenez JF,
Sotelo Rodriguez T, Aguado JM, Rodriguez Hernandez E.
Mycotic aneurysm caused by Aspergillus of the aortic
suture line after heart transplantation. Rev Esp Cardiol
2000; 53: 1403–1405.
92. Rao NA, Hidayat A. A comparative clinicopathologic
study of endogenous mycotic endophthalmitis: variations
in clinical and histopathologic changes in candidiasis
compared to aspergillosis. Trans Am Ophthalmol Soc 2000;
98: 183–193.
93. Atkinson JB, Connor DH, Robinowitz M, McAllister
HA, Virmani R. Cardiac fungal infections: review of
autopsy ﬁndings in 60 patients. Hum Pathol 1984; 15:
935–942.
94. Walsh TJ, Hutchins GM, Bulkley BH, Mendelsohn G.
Fungal infections of the heart: analysis of 51 autopsy
cases. Am J Cardiol 1980; 45: 357–366.
95. Wain W, Ahmed M, Thompson R, Yacoub M. The role of
chemotherapy in the management of fungal endocarditis
following homograft valve replacement. Postgrad Med J
1979; 55: 629–631.
96. Raghavan R, Krishnaswami H, Date A. Experience with
fungal infections affecting the heart in necropsies at an
Indian hospital. Trans R Soc Trop Med Hyg 1989; 83: 563–
564.
97. Mencl K, Otcenasek M, Spacek J, Rehulova E. Aspergillus
restrictus and Candida parapsilosis—agents of endocarditis
following heart valve replacement.Mykosen 1985; 28: 127–
133.
98. Stein PD, Harken DE, Dexter L. The nature and preven-
tion of prosthetic valve endocarditis. Am Heart J 1966; 71:
393–407.
99. Cherubin CE, Neu HC. Infective endocarditis at the
Presbyterian Hospital in New York City from 1938–1967.
Am J Med 1938; 51: 83–96.
100. Choudhary SK, Talwar S, Kumar AS. Bentall operation
with valved homograft conduit. Tex Heart Inst J 2000; 27:
366–368.
101. Puig LB, Verginelli G, Kawabe L et al. Four years
experience with dura mater cardiac valves. J Cardiovasc
Surg (Torino) 1977; 18: 247–255.
102. Vogeser M, Wanders A, Haas A, Ruckdeschel G. A four-
year review of fatal aspergillosis. Eur J Clin Microbiol
Infect Dis 1999; 18: 42–45.
103. Boyd AD, Spencer FC, Isom OW et al. Infective endo-
carditis. An analysis of 54 surgically treated patients.
J Thorac Cardiovasc Surg 1977; 73: 23–30.
104. Arnett EN, Roberts WC. Prosthetic valve endocarditis:
clinicopathologic analysis of 22 necropsy patients with
comparison observations in 74 necropsy patients with
active infective endocarditis involving natural left-sided
cardiac valves. Am J Cardiol 1976; 38: 281–292.
105. Anonymous. News and notes, epidemiology: mycosis.
BMJ 1970; ii: 185.
106. Clarkson PM, Barratt-Boyes BG. Bacterial endocarditis
following homograft replacement of the aortic valve.
Circulation 1970; 42: 987–991.
107. Kalil RAK, Macedo RG, Prates PR et al. Re-operations
following Bentall–De Bono operation for anulo-aortic
ectasia. Rev Brasil Cirurg Cardiovasc 1988; 3: 93–100.
108. Chen SC, Sorrell TC, Dwyer DE, Collignon PJ, Wright EJ.
Endocarditis associated with prosthetic cardiac valves.
Med J Aust 1990; 152: 458–463.
109. Semb BK, Hall KV, Nitter-Hauge S, Abdelnoor M. A
5-year follow-up of the Medtronic–Hall valve: survival
and thromboembolism. Thorac Cardiovasc Surg 1983; 31:
61–65.
110. Coutlee F, Carceller AM, Deschamps L, Kratz C, Lapointe
JR, Davignon A. The evolving pattern of pediatric endo-
carditis from 1960 to 1985. Can J Cardiol 1990; 6: 164–170.
111. Stanulla H. Mycotic prosthetic valve endocarditis. Zen-
tralbl Allgem Pathol Pathol Anat 1983; 127: 97–103.
112. Pospisil K, Strata K, Otcenasek M et al.Mycotic ulcerative
aortitis after replacement of the aortic valve caused by the
fungus Aspergillus restrictus. Vnitr Lek 1984; 30: 292–297.
113. Kawasaki S, Naitoh Y, Takagaki Y, Komai Y, Noguchi Y.
Two cases of Aspergillus endocarditis after cardiac sur-
gery in childhood. Kyobu Geka 1996; 49 (suppl 8): 673–676.
114. Katayama Y, Okabe M, Mizutani T, Yada I, Yuasa H,
Kusagawa M. Treatment of prosthetic valve endo-
Pasqualotto and Denning Post-operative aspergillosis 1069
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 1060–1076
carditis—analysis of eleven cases. Nippon Kyobu Geka
Gakkai Zasshi 1989; 37: 2111–2116.
115. Otto T, Halweg H, Pietraszek A, Kaminski Z. Aspergillus
endocarditis following aortic valve replacement. Kardiol
Pol 1979; 22: 221–226.
116. Nakanishi M, Teramoto S, Doi T, Mihara Y, Nasu M. Case
of Aspergillus endocarditis following aortic valve
replacement. Kyobu Geka 1973; 26: 432–436.
117. Grabowski H, Holak L, Musiatowicz B. Case of Asperg-
illus endocarditis in a patient following surgery for
Fallot’s tetralogy. Pol Tyg Lek 1971; 26: 520–521.
118. Tomsova M. Mycotic diseases of the heart. Cesk Patol
2001; 37: 172–176.
119. Dudkiewicz B, Szewczyk E. Etiology of bacterial endo-
carditis in materials from Cardiology and Cardiac Sur-
gery Clinics of the Lodz Academy. Med Dosw Mikrobiol
1993; 45: 357–359.
120. Sakashita I, Otani S, Terashima M, Equchi A, Nakamura
C. A study on the relationship between prosthetic valve
replacement and infective endocarditis before and after
surgery. Part 2. With special reference to prosthetic valve
endocarditis. Nippon Kyobu Geka Gakkai Zasshi 1979; 27:
1537–1543.
121. Wellens F, Potvliege C, Deuvaert FE, Primo G. Aspergillus
osteochondritis after median sternotomy. Combined
operative treatment and drug therapy with amphotericin
B. Thorac Cardiovasc Surg 1982; 30: 322–324.
122. Sachs MK, Paluzzi RG, Moore JH, Fraimow HS, Ost D.
Amphotericin-resistant Aspergillus osteomyelitis con-
trolled by itraconazole. Lancet 1990; 335: 1475.
123. Vandecasteele SJ, Boelaert JR, Verrelst P, Graulus E,
Gordts BZ. Diagnosis and treatment of Aspergillus ﬂavus
sternal wound infections after cardiac surgery. Clin Infect
Dis 2002; 35: 887–890.
124. Elahi MM, Mitra A, Spears J, McClurken JB. Recalcitrant
chest wall Aspergillus fumigatus osteomyelitis after cor-
onary artery bypass grafting: successful radical surgical
and medical management. Ann Thorac Surg 2005; 79:
1057–1059.
125. Barzaghi N, Emmi V, Mencherini S, Minzioni G, Marone
P, Minoli L. Sternal osteomyelitis due to Aspergillus fu-
migatus after cardiac surgery. Chest 1994; 105: 1275–1277.
126. Whiting RB, Barner HB, Leone P, Westura EE. Aspergil-
loma: an unusual cause of late failure of aortocoronary
bypass graft. Chest 1973; 63: 1030–1033.
127. Draganov J, Klein HM, Ghodsizad A, Gehrke M, Gams E.
Rupture of a saphenous vein coronary artery bypass graft
due to Aspergillus necrotizing vasculitis. Ann Thorac Surg
2005; 80: 724–726.
128. Pema´n J, Ortı´z R, Osseyran F et al. Non-surgical endo-
carditis by Aspergillus with mould isolation in blood
culture and negative galactomannan. Mycoses 2005; 48
(suppl 2): 45.
129. Frank KA, Merz WG, Hutchins GM. Sclerotium forma-
tion in an Aspergillus ﬂavus wound infection. Mycopatho-
logia 1988; 102: 185–188.
130. Sawyer RG, Schenk WG, Adams RB, Pruett TL. Asperg-
illus ﬂavuswound infection following repair of a ruptured
duodenum in a non-immunocompromised host. Scand J
Infect Dis 1992; 24: 805–809.
131. Yuen JC, Puri SK, Feng Z. Scalp necrotizing fasciitis with
osteomyelitis of the skull from Aspergillus. J Craniofac Surg
2002; 13: 762–764.
132. Falsey AR, Goldsticker D, Ahem MJ. Fatal subcutaneous
aspergillosis following necrotizing fasciitis: a case report.
Yale J Biol Med 1990; 63: 9–13.
133. Sergi C, Weitz J, Hofmann WJ et al. Aspergillus endocar-
ditis, myocarditis and pericarditis complicating necro-
tizing fasciitis. Case report and subject review. Virchows
Arch 1996; 429: 177–180.
134. Johnson MA, Lyle G, Hanly M, Yeh KA. Aspergillus: a rare
primary organism in soft-tissue infections. Am Surg 1998;
64: 122–126.
135. Lai CS, Lin SD, Chou CK, Lin HJ. Aspergillosis compli-
cating the grafted skin and free muscle ﬂap in a diabetic.
Plast Reconstr Surg 1993; 92: 532–536.
136. Anderson LL, Giandoni MB, Keller RA, Grabski WJ.
Surgical wound healing complicated by Aspergillus
infection in a nonimmunocompromised host. Dermatol
Surg 1995; 21: 799–801.
137. Attah CA, Cerruti MM. Aspergillus osteomyelitis of ster-
num after cardiac surgery. NY State J Med 1979; 79: 1420–
1421.
138. Langlois RP, Flegel KM, Meakins JL, Morehouse DD,
Robson HG, Guttmann RD. Cutaneous aspergillosis with
fatal dissemination in a renal transplant recipient. Can
Med Assoc J 1980; 120: 673–676.
139. Nampoory MR, Khan ZU, Johny KV et al. Invasive fungal
infections in renal transplant recipients. J Infect 1996; 33:
95–101.
140. Grossi P, Farina C, Fiocchi R, Dalla Gasperina D.
Prevalence and outcome of invasive fungal infections
in 1,963 thoracic organ transplant recipients: a multi-
center retrospective study. Transplantation 2000; 70:
112–116.
141. Le Conte P, Blanloeil Y, Michel P, Francois T, Paineau J.
Cutaneous aspergillosis in a patient with orthotopic
hepatic transplantation. Transplantation 1992; 53: 1153–
1154.
142. Pla´ MP, Berenguer J, Arzuaga JA, Baﬁares R, Polo JR,
Bouza E. Surgical wound infection by Aspergillus fumig-
atus in liver transplant recipients. Diagn Microbiol Infect
Dis 1992; 15: 703–706.
143. Pegues DA, Lasker BA, McNeil MM, Hamm PM, Lundal
JL, Kubak BM. Cluster of cases of invasive aspergillosis in
a transplant intensive care unit: evidence of person-to-
person airborne transmission. Clin Infect Dis 2002; 34: 412–
416.
144. Richet HM, McNeil MM, Davis BJ et al. Aspergillus fu-
migatus sternal wound infections in patients undergoing
open heart surgery. Am J Epidemiol 1992; 135: 48–58.
145. Bryce EA, Walker M, Scharf S et al. An outbreak of
cutaneous aspergillosis in a tertiary-care hospital. Infect
Control Hosp Epidemiol 1996; 17: 170–172.
146. Marples RR. Contaminated ﬁrst-aid dressings: report of a
Working Party of the PHLS. J Hyg 1983; 90: 241–252.
147. Patterson JE, Barden GE, Bia FJ. Hospital-acquired
gangrenous mucormycosis. Yale J Biol Med 1986; 59:
453–459.
148. Florio M, Marroni M, Morosi S, Stagni G. Nosocomial
Aspergillus ﬂavus wound infections following cardiac
surgery. Infez Med 2004; 12: 270–273.
149. Siddiqui AA, Shah AA, Bashir SH. Craniocerebral
aspergillosis of sinonasal origin in immunocompetent
patients: clinical spectrum and outcome in 25 cases.
Neurosurgery 2004; 55: 602–613.
1070 Clinical Microbiology and Infection, Volume 12 Number 11, November 2006
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 1060–1076
150. Visudhiphan P, Bunyaratavej S, Khantanaphar S. Cereb-
ral aspergillosis. Report of three cases. J Neurosurg 1973;
38: 472–476.
151. Shapiro K, Tabaddor K. Cerebral aspergillosis. Surg
Neurol 1975; 4: 465–471.
152. Feely M, Steinberg M. Aspergillus infection complicating
transphenoidal yttrium-90 pituitary implant. Report of
two cases. J Neurosurg 1977; 46: 530–532.
153. Morioka T, Tashima T, Nagata S, Fukui M, Hasuo K.
Cerebral aspergillosis after burr-hole surgery for chronic
subdural hematoma: case report. Neurosurgery 1990; 26:
332–335.
154. Galassi E, Pozzati E, Poppi M, Vinci A. Cerebral asper-
gillosis following intracranial surgery. Case report.
J Neurosurg 1978; 49: 308–311.
155. Hajjar J, Brunon J, Jaubert J et al. Cerebral aspergillosis.
Apropos of 4 cases. Neurochirurgie 1987; 33: 142–147.
156. Mielke B, Weir B, Oldring D, von Westarp C. Fungal
aneurysm: case report and review of the literature. Neu-
rosurgery 1981; 9: 578–582.
157. Ouammou A, el Ouarzazi A, Belghmaidi M, el Faidouzi
M. Cerebral aspergillosis and encephalomeningocele.
Childs Nerv Syst 1986; 2: 216–218.
158. Piotrowski WP, Pilz P, Chuang IH. Subarachnoid
hemorrhage caused by a fungal aneurysm of the
vertebral artery as a complication of intracranial
aneurysm clipping. Case report. J Neurosurg 1990; 73:
962–964.
159. Kim DG, Hong SC, Kim HJ et al. Cerebral aspergillosis in
immunologically competent patients. Surg Neurol 1993;
40: 326–331.
160. Komatsu Y, Narushima K, Kobayashi E, Tomono Y, Nose
T. Aspergillusmycotic aneurysm—case report. Neurol Med
Chir (Tokyo) 1991; 31: 346–350.
161. Darras-Joly C, Veber B, Bedos JP, Gachot B, Regnier B,
Wolff M. Nosocomial cerebral aspergillosis: a report of 3
cases. Scand J Infect Dis 1996; 28: 317–319.
162. Sharma RR, Gurusinghe NT, Lynch PG. Cerebral infarc-
tion due to Aspergillus arteritis following glioma surgery.
Br J Neurosurg 1992; 6: 485–490.
163. Beal MF, O’Carroll CP, Kleinman GM, Grossman RI.
Aspergillosis of the nervous system. Neurology 1982; 32:
473–479.
164. Viriyavejakul P, Phudhichareonrat S, Boonpasat Y et al.
Intracerebral hemorrhage due to nosocomial aspergillosis
following neurosurgery. SE Asian J Trop Med Pub Hlth
1999; 30: 154–156.
165. Letscher V, Herbrecht R, Gaudias J et al. Post-traumatic
intracranial epidural Aspergillus fumigatus abscess. J Med
Vet Mycol 1997; 35: 279–282.
166. Takeshita M, Izawa M, Kubo O et al. Aspergillotic
aneurysm formation of cerebral artery following neuro-
surgical operation. Surg Neurol 1992; 38: 146–151.
167. Cuccia V, Galarza M, Monges J. Cerebral aspergillosis in
children. Report of three cases. Pediatr Neurosurg 2000; 33:
43–48.
168. Endo T, Numagami Y, Jokura H, Ikeda H, Shirane R,
Yoshimoto T. Aspergillus parasellar abscess mimicking
radiation-induced neuropathy. Case report. Surg Neurol
2001; 56: 195–200.
169. Theaker ED, Rushton VE, Corcoran JP, Hatton P. Chronic
sinusitis and zinc-containing endodontic obturating
pastes. Br Dent J 1995; 179: 64–68.
170. Legent F, Beauvillain C, Mercier J, Hofmann B, Wesoluch
M. Relations between sinus aspergillosis, primary rhino-
liths and dental pathology. Ann Otolaryngol Chir Cervico-
fac 1982; 99: 541–545.
171. Beck-Mannagetta J, Necek D, Grasserbauer M. Dental
aspects of solitary maxillary sinus aspergillosis. A clin-
ical, microanalytical and experimental study. Z Stomatol
1986; 83: 283–315.
172. Legent F, Billet J, Beauvillain C, Bonnet J, Miegeville M.
The role of dental canal ﬁllings in the development of
Aspergillus sinusitis. A report of 85 cases. Arch Otorhino-
laryngol 1989; 246: 318–320.
173. De Foer C, Fossion E, Vaillant JM. Sinus aspergillosis.
J Craniomaxillofac Surg 1990; 18: 33–40.
174. Bader G. Aspergillus sinusitis of dental origin. Rev
Odontostomatol (Paris) 1989; 18: 345–353.
175. Buffe P, Nottet JB, Poncet JL. Maxillary Aspergillus
sinusitis. Comments apropos of 20 cases. Rev Laryngol
Otol Rhinol (Bord) 1992; 113: 197–200.
176. Khongkhunthian P, Reichart PA. Aspergillosis of the
maxillary sinus as a complication of overﬁlling root canal
material into the sinus: report of two cases. J Endod 2001;
27: 476–478.
177. Rodriguez V, Bardwil JM, Bodey GP. Primary aspergil-
loma cured with amphotericin B. South Med J 1971; 64:
396–398.
178. Beck-Mannagetta J, Necek D. Radiologic ﬁndings in
aspergillosis of the maxillary sinus. Oral Surg Oral Med
Oral Pathol 1986; 62: 345–349.
179. Krennmair G, Lenglinger F, Laine FJ. Maxillary sinus
aspergillosis: diagnosis and differentiation of the patho-
genesis based on computed tomography densitometry of
sinus concretions. J Oral Maxillofac Surg 1995; 53: 657–664.
180. Legend F, Desnos J, Beauvillain C. Aspergillus sinusi-
ennes. J Fr Otorhinolaryngol Audiophonol Chirurg Maxillofac
1980, 29: 39–49.
181. Martins WD, Ribeiro Rosa EA. Aspergillosis of the max-
illary sinus: review and case report. Scand J Infect Dis
2004; 36: 758–761.
182. Beck-Mannagetta J, Necek D, Grasserbauer M. Solitary
aspergillosis of maxillary sinus, a complication of dental
treatment. Lancet 1983; ii: 1260.
183. Gonty AA, Page LR. Aspergillosis of the maxillary sinus.
Review of the literature and report of a case. Oral Surg
Oral Med Oral Pathol 1977; 43: 350–356.
184. Brar GS, Ram J, Kaushik S, Chakraborti A, Dogra MR,
Gupta A. Aspergillus niger endophthalmitis after cataract
surgery. J Cataract Refract Surg 2002; 28: 1882–1883.
185. Mendicute J, Orbegozo J, Ruiz M, Saiz A, Eder F,
Aramberri J. Keratomycosis after cataract surgery.
J Cataract Refract Surg 2000; 26: 1660–1666.
186. Kermani NK, Aggarwal SP. Isolated post-operative As-
pergillus niger endophthalmitis. Eye 2000; 14: 114–116.
187. Das T, Vyas P, Sharma S. Aspergillus terreus postoperative
endophthalmitis. Br J Ophthalmol 1993; 77: 386–387.
188. Kloess PM, Stulting RD, Waring GO, Wilson LA. Bacterial
and fungal endophthalmitis after penetrating keratopl-
asty. Am J Ophthalmol 1993; 115: 309–316.
189. Weichel ED, Bower KS, Ward TP, Hidayat A. Epicorneal
aspergilloma after penetrating keratoplasty. Cornea 2002;
21: 825–827.
190. Cameron JA, Antonios SR, Cotter JB, Habash NR. End-
ophthalmitis from contaminated donor corneas following
Pasqualotto and Denning Post-operative aspergillosis 1071
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 1060–1076
penetrating keratoplasty. Arch Ophthalmol 1991; 109:
54–59.
191. Heidemann DG, Dunn SP, Watts JC. Aspergillus keratitis
after radial keratotomy. Am J Ophthalmol 1995; 120: 254–
256.
192. Panda A, Das GK, Vanathi M, Kumar A. Corneal infec-
tion after radial keratotomy. J Cataract Refractive Surg
1998; 24: 331–334.
193. Maskin SL, Alfonso E. Fungal keratitis after radial
keratotomy. Am J Ophthalmol 1992; 114: 369–370.
194. de Sousa LB, Cronemberger MF, Campos M, Nose W.
Penetrating keratoplasty in the treatment of fungal kera-
titis after radial keratotomy: report of 3 cases. Arquivos
Brasil Oftalmol 1995; 58: 47–49.
195. Dunphy D, Andrews D, Seamone C, Ramsey M. Fungal
keratitis following excimer laser photorefractive keratec-
tomy. Can J Ophthalmol 1999; 34: 286–289.
196. Kuo IC, Margolis TP, Cevallos V, Hwang DG. Aspergillus
fumigatus keratitis after laser in situ keratomileusis.
Cornea 2001; 20: 342–344.
197. Sridhar MS, Garg P, Bansal AK, Gopinathan U. Aspergil-
lus ﬂavus keratitis following laser in situ keratomileusis.
Am J Ophthalmol 2000; 129: 802–804.
198. Ritterband D, Kelly J, McNamara T, Kresloff M, Koplin R,
Seedor J. Delayed-onset multifocal polymicrobial keratitis
after laser in situ keratomileusis. J Cataract Refractive Surg
2002; 28: 898–899.
199. Tehrani M, Dick HB, Daeschlein G, Kramer A. Microbial
keratitis following laser in situ keratomileusis. Preven-
tion, differential diagnosis, and therapy. Ophthalmologe
2005; 102: 514–519.
200. Margo CE, Polack FM, Hood CI. Aspergillus panopht-
halmitis complicating treatment of pterygium. Cornea
1988; 7: 285–289.
201. Hsiao CH, Chen JJY, Huang SCM,MaHK, Chen PYF, Tsai
RJF. Intrascleral dissemination of infectious scleritis fol-
lowing pterygiumexcision.Br J Ophthalmol 1998; 82: 29–34.
202. Oestreicher JH, Bashour M, Jong R, Chiu B. Aspergillus
mycetoma in a secondary hydroxyapatite orbital implant:
a case report and literature review. Ophthalmology 1999;
106: 987–991.
203. Mendicute J, Ondarra A, Eder F, Ostolaza JI, Salaberria
M, Lamsfus JM. The use of collagen shields impregnated
with amphotericin B to treat Aspergillus keratomycosis.
CLAO J 1995; 21: 252–255.
204. Bernauer W, Allan BDS, Dart JK. Successful management
of Aspergillus scleritis by medical and surgical treatment.
Eye 1998; 12: 311–316.
205. Carlson AN, Foulks GN, Perfect JR, Kim JH. Fungal
scleritis after cataract surgery. Successful outcome using
itraconazole. Cornea 1992; 11: 151–154.
206. Oshitari K, Hirakata A, Okada AA et al. Vitrectomy for
endophthalmitis after cataract surgery. Nippon Ganka
Gakkai Zasshi 2003; 107: 590–596.
207. Valenton M. Wound infection after cataract surgery. Jpn J
Ophthalmol 1996; 40: 447–455.
208. Narang S, Gupta A, Gupta V et al. Fungal endopht-
halmitis following cataract surgery: clinical presentation,
microbiological spectrum, and outcome. Am J Ophthalmol
2001; 132: 609–617.
209. Tabbara KF, al Jabarti AL. Hospital construction-associ-
ated outbreak of ocular aspergillosis after cataract sur-
gery. Ophthalmology 1998; 105: 522–526.
210. Gupta A, Gupta V, Gupta A et al. Spectrum and clinical
proﬁle of post cataract surgery endophthalmitis in North
India. Ind J Ophthalmol 2003; 51: 139–145.
211. Tasaka Y, Fujii S. Fungal endophthalmitis following in-
traocular lens implantation. A case report. Folia Ophthal-
mol Jpn 1990; 41: 1338–1344.
212. Mahajan VM. Postoperative ocular infections. An analysis
of laboratory data on 750 cases. Ann Ophthalmol 1984; 16:
847–848.
213. Kondo T, Yoshida H. Fungal infection following scleral
buckling procedures. Folia Ophthalmol Jpn 1974; 25: 781–
787.
214. Newton JC, Fowler BJ. Aspergillus infection of a scleral
implant. Ann Ophthalmol 1980; 12: 952–954.
215. Garg P, Mahesh S, Bansal AK, Gopinathan U, Rao GN.
Fungal infection of sutureless self-sealing incision for
cataract surgery. Ophthalmology 2003; 110: 2173–2177.
216. Oxford K, Abbott RL, Fung WE, Ellis DS. Aspergillus
endophthalmitis after sutureless cataract surgery. Am J
Ophthalmol 1995; 120: 534–535.
217. Krzystolik MG, Ciulla TA, Topping TM, Baker AS. Exo-
genous Aspergillus niger endophthalmitis in a patient with
a ﬁltering bleb. Retina 1997; 17: 461–462.
218. Alexandris G, Haimovici R, Miller D et al. Corneal biopsy
in the management of progressive microbial keratitis. Am
J Ophthalmol 2000; 129: 571–577.
219. Thomas PA. Current perspectives on ophthalmic myc-
oses. Clin Microbiol Rev 2003; 16: 730–797.
220. Ishibashi Y, Kaufman HE. Corneal biopsy in the diag-
nosis of keratomycosis. Am J Ophthalmol 1986; 101: 288–
293.
221. Burt B, Pappas G, Simcock P. Hospital acquired Asperg-
illus keratitis. Br J Ophthalmol 2003; 87: 923.
222. Fahad B, McKellar M, Armstrong M, Denning D, Tullo A.
Aspergillus keratitis following corneal foreign body. Br J
Ophthalmol 2004; 88: 847–848.
223. Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and
parasitic infections of the eye. Clin Microbiol Rev 2000; 13:
662–685.
224. Rosa RH, Miller D, Alfonso EC. The changing spectrum
of fungal keratitis in South Florida. Ophthalmology 1994;
101: 1005–1013.
225. Wong TY, Ng TP, Fong KS, Tan DT. Risk factors and
clinical outcome between fungal and bacterial keratitis. A
comparative study. CLAO J 1997; 23: 275–281.
226. Armstrong RA. The microbiology of the eye. Ophthalmic
Physiol Opt 2000; 20: 429–441.
227. Gopinathan U, Garg P, Fernandes M, Sharma S, Ath-
manathan S, Rao GN. The epidemiological features and
laboratory results of fungal keratitis: a 10-year review at a
referral eye care center in South India. Cornea 2002; 21:
555–559.
228. Karimov MK. Mycotic infections as possible complica-
tions in penetrating eye injuries. Oftalmol Zh 1981; 36:
214–216.
229. Anonymous. Direct fungal infection of the eye and its
prevention. Br J Ophthalmol 1976; 60: 605–606.
230. Hanish SJ, Perlmutter JC, Boucher C, Bohigian G, Grand
MG. Exogenous Aspergillus endophthalmitis. Ann Oph-
thalmol 1984; 16: 417–419.
231. Ho PC, Tolentino FI, Baker AS. Successful treatment of
exogenous Aspergillus endophthalmitis: a case report. Br J
Ophthalmol 1984; 68: 412–415.
1072 Clinical Microbiology and Infection, Volume 12 Number 11, November 2006
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 1060–1076
232. Kaushik S, Ram J, Brar GS, Jain AK, Chakraborti A, Gupta
A. Intracameral amphotericin B: initial experience in
severe keratomycosis. Cornea 2001; 20: 715–719.
233. Abu el-Asrar AM, al-Amro SA, al-Mosallam AA, al-
Obeidan S. Post-traumatic endophthalmitis: causative
organisms and visual outcome. Eur J Ophthalmol 1999; 9:
21–31.
234. Carranza R, Lopez N, Gonzalez F, Dominguez J, Amigo
A, Martinez F. Ocular perforation in the agrarian envi-
ronment. Enferm Infecc Microbiol Clin 1998; 16: 377–378.
235. Hirose H, Terasaki H, Awaya S, Yasuma T. Treatment of
fungal corneal ulcers with amphotericin B ointment. Am J
Ophthalmol 1997; 124: 836–838.
236. Kulshrestha M, Palimar P. Corneal ulcers in paddy
workers in south India. Occup Med (Lond) 1996; 46: 320.
237. Rodriguez-Ares MT, De Rojas Silva MV, Pereiro M, Fente
Sampayo B, Gallegos Chamas GS, Salorio M. Aspergillus
fumigatus scleritis. Acta Ophthalmol Scand 1995; 73: 467–
469.
238. Ariyasu RG, Kumar S, LaBree LD, Wagner DG, Smith RE.
Microorganisms cultured from the anterior chamber of
ruptured globes at the time of repair. Am J Ophthalmol
1995; 119: 181–188.
239. Upadhyay MP, Karmacharya PC, Koirala S et al.
Epidemiologic characteristics, predisposing factors, and
etiologic diagnosis of corneal ulceration in Nepal. Am J
Ophthalmol 1991; 111: 92–99.
240. Lubniewski A, Olk RJ, Grand MG. Ocular dangers in the
garden. A new menace—nylon line lawn trimmers.
Ophthalmology 1988; 95: 906–910.
241. Srinivasan M, Gonzales CA, George C et al. Epidemiol-
ogy and aetiological diagnosis of corneal ulceration
in Madurai, south India. Br J Ophthalmol 1997; 81:
965–971.
242. Gugnani HC, Talwar RS, Njoku-Obi AN, Kodilinye HC.
Mycotic keratitis in Nigeria. A study of 21 cases. Br J
Ophthalmol 1976; 60: 607–613.
243. Koul RL, Pratap VB. Keratomycosis in Lucknow. Br J
Ophthalmol 1975; 59: 47–51.
244. O’Day DM, Moore TE, Aronson SB. Deep fungal corneal
abscess. Combined corticosteroid therapy. Arch Ophthal-
mol 1971; 86: 414–419.
245. Vemuganti GK, Garg P, Gopinathan U et al. Evaluation of
agent and host factors in progression of mycotic keratitis:
a histologic and microbiologic study of 167 corneal but-
tons. Ophthalmology 2002; 109: 1538–1546.
246. Wood TO, Tuberville AW, Monnett R. Keratomycosis
and amphotericin B. Trans Am Ophthalmol Soc 1985; 83:
397–409.
247. Gonawardena SA, Ranasinghe KP, Arseculeratne SN,
Seimon CR, Ajello L. Survey of mycotic and bacterial
keratitis in Sri Lanka. Mycopathologia 1994; 127: 77–81.
248. Giobbia M, Rossi MC, Conti E et al. Post-traumatic As-
pergillus fumigatus keratitis. J Mycol Med 2002; 12: 32–33.
249. Hariprasad SM, Mieler WF, Holz ER et al. Determination
of vitreous, aqueous, and plasma concentration of orally
administered voriconazole in humans. Arch Ophthalmol
2004; 122: 42–47.
250. Tack KJ, Rhame FS, Brown B, Thompson RC. Aspergillus
osteomyelitis. Report of four cases and review of the lit-
erature. Am J Med 1982; 73: 295–300.
251. Peters-Christodoulou MN, de Beer FC, Bots GT, Ottenh-
off TM, Thompson J, van’t Wout JW. Treatment of post-
operative Aspergillus fumigatus spondylodiscitis with
itraconazole. Scand J Infect Dis 1991; 23: 373–376.
252. Mawk JR, Erickson DL, Chou SN, Seljeskog EL. Asperg-
illus infections of the lumbar disc spaces. Report of three
cases. J Neurosurg 1983; 58: 270–274.
253. Dabrowski LC, Marchou B, Dabrowski A. Spondylodi-
scites aspergillaires: a` propos de 3 cas et revue de la
literature. Med Mal Infect 2003; 33: 258–265.
254. Lenzi J, Agrillo A, Santoro A, Marotta N, Cantore GP.
Postoperative spondylodiscitis from Aspergillus fumigatus
in immunocompetent subjects. J Neurosurg Sci 2004; 48:
81–85.
255. Fitzgerald RH, Peterson LF, Washington JA, Van Scoy
RE, Coventry MB. Bacterial colonization of wounds and
sepsis in total hip arthroplasty. J Bone Joint Surg Am 1973;
55: 1242–1250.
256. Cimerman M, Gunde-Cimerman N, Zalar P, Perkovic T.
Femur osteomyelitis due to a mixed fungal infection in a
previously healthy man. J Clin Microbiol 1999; 37: 1532–
1535.
257. Brook I, Aaron RK. Hospital-acquired Aspergillus ﬂavus
infection in a surgical wound: a case report. Orthopedics
1980; 3: 1215–1216.
258. Austin KS, Testa NN, Luntz RK, Greene JB, Smiles S.
Aspergillus infection of total knee arthroplasty presenting
as a popliteal cyst. Case report and review of the litera-
ture. J Arthroplasty 1992; 7: 311–314.
259. Baumann PA, Cunningham B, Patel NS, Finn HA. As-
pergillus fumigatus infection in a mega prosthetic total
knee arthroplasty: salvage by staged reimplantation with
5-year follow-up. J Arthroplasty 2001; 16: 498–503.
260. Langer P, Kassim RA, Macari GS, Saleh KJ. Aspergillus
infection after total knee arthroplasty. Am J Orthop 2003;
32: 402–404.
261. Kelemen S, Novak E. Mycotic stitch abscess after lobec-
tomy (Aspergillus infection) cured by antibiotic therapy.
Beitr Klin Tuberk Spezif Tuberkuloseforsch 1960; 121: 654–
658.
262. Roig J, Ruiz J, Puig X, Carreras A, Morera J. Bronchial
stump aspergillosis four years after lobectomy. Chest
1993; 104: 295–296.
263. Noppen M, Claes I, Maillet B, Meysman M, Monsieur I,
Vincken W. Three cases of bronchial stump aspergillosis:
unusual clinical presentations and beneﬁcial effect of oral
itraconazole. Eur Respir J 1995; 8: 477–480.
264. Le Rochais JP, Icard P, Simon T, Poirier P, Evrard C.
Bronchial stump aspergillosis. Ann Thorac Surg 2000; 70:
302–304.
265. Zajaczkowska J, Halweg H, Pirozynski M, Olechnowicz
H, Podsiadlo B, Krakowka P. Further studies on the
occurrence of mycoses in the bronchial stump and
bronchial anastomosis or trachea. Pneumonol Pol 1989; 57:
104–113.
266. Filippov VP, Lebedev KM, Sofronii SV. Mycotic lesions of
the stump of the resected bronchus. Grudn Khir 1980; 5:
72–74.
267. Krakowka P, Halweg H, Nowicki J, Zajaczkowska J.
Aspergillosis of the bronchial stump following resec-
tion of pulmonary tissue. Pol Przegl Chir 1969; 41:
242–247.
268. Franke H, Ammen K, Haering R. On the problem of the
suture for bronchial closure: observation on mycoses of
the bronchial stump. Thoraxchirurgie 1961; 8: 621–626.
Pasqualotto and Denning Post-operative aspergillosis 1073
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 1060–1076
269. Sawasaki H, Horie K, Yamada M et al. Bronchial stump
aspergillosis. Experimental and clinical study. J Thorac
Cardiovasc Surg 1969; 58: 198–208.
270. Katsura H, Iuchi K, Matsumura A. Pulmonary suture
granuloma with Aspergillus after partial resection for lung
cancer; report of a case. Kyobu Geka 2005; 58: 169–171.
271. Nunley DR, Gal AA, Veja JD, Perlino C, Smith P, Law-
rence EC. Saprophytic fungal infections and complica-
tions involving the bronchial anastomosis following
human lung transplantation. Chest 2002; 122: 1185–1191.
272. Kramer MR, Denning DW, Marshall SE et al. Ulcerative
tracheobronchitis after lung transplantation: a new form
of invasive aspergillosis. Am Rev Respir Dis 1991; 144:
552–556.
273. Bertocchi M, Thevenet F, Bastien O et al. Fungal infec-
tions in lung transplant recipients. Transplant Proc 1995;
27: 1695.
274. Guillemain R, Lavarde V, Amrein C, Chevalier P,
Guinvarc’h A, Glotz D. Invasive aspergillosis after
transplantation. Transplant Proc 1995; 27: 1307–1309.
275. Patterson DL, Singh N. Invasive aspergillosis in trans-
plant recipients. Medicine (Baltimore) 1999; 78: 123–138.
276. Tezer Y, Memikoglu O, Kart H. Iatrogenic pleural asper-
gillosis treated with combination of systemic and intra-
pleural amphotericin B. Mycoses 2005; 48 (suppl 2): 43.
277. Glotzbach RE. Aspergillus terreus infection of pseudoan-
eurysm of aortofemoral vascular graft with contiguous
vertebral osteomyelitis. Am J Clin Pathol 1982; 77: 224–227.
278. Brandt SJ, Thompson RL, Wenzel RP. Mycotic pseudo-
aneurysm of an aortic bypass graft and contiguous ver-
tebral osteomyelitis due to Aspergillus fumigatus. Am J
Med 1985; 79: 259–262.
279. Doscher W, Krishnasastry KV, Deckoff SL. Fungal graft
infections: case report and review of the literature. J Vasc
Surg 1987; 6: 398–402.
280. Aguado JM, Valle R, Arjona R, Ferreres JC, Gutierrez JA.
Aortic bypass graft infection due to Aspergillus: report of
a case and review. Clin Infect Dis 1992; 14: 916–921.
281. Echene B, Brunel D, Astruc J, Perez C. Aspergillose dis-
se´mine´e chez un enfant porteur d’une prosthe`se aortique.
Med Mal Infect 1980; 10: 263–266.
282. Anderson J, Kron IL. Treatment of Aspergillus infection
of the proximal aortic prosthetic graft with associated
vertebral osteomyelitis. J Vasc Surg 1984; 1: 579–581.
283. Hargrove WC, Edmunds LH. Management of infected
thoracic aortic prosthetic grafts. Ann Thorac Surg 1984; 37:
72–77.
284. Nussaume O, Elzaabi M, Icard P, Branger C, Bouttier S,
Andreassian B. False aneurysm infected by Aspergillus
fumigatus: an unusual complication of aortofemoral by-
pass graft. Ann Vasc Surg 1990; 4: 388–392.
285. Collazos J, Mayo J, Martinez E, Ibarra S. Prosthetic vas-
cular graft infection due to Aspergillus species: case report
and literature review. Eur J Clin Microbiol Infect Dis 2001;
20: 414–417.
286. Lifschultz BD, Leestma JE, Stryker S. Multiple mycotic
aneurysms and transverse myelopathy complicating re-
pair of aortic coarctation. Ann Thorac Surg 1982; 33: 192–
196.
287. Motte S, Bellens B, Rickaert F, Serruys E, Thys JP, Dere-
ume JP. Vascular graft infection caused by Aspergillus
species: case report and review of the literature. J Vasc
Surg 1993; 17: 607–612.
288. Sa´nchez Lastres J, Rodrı´guez Nu´n˜ez A, Alvez Gonza´lez F
et al. Infeccio´n por Aspergillus de pro´tesis vascular en
nin˜o con coartacio´n ao´rtica. Implicaciones evolutivas y
terape´uticas. An Esp Pediatr 1993; 38: 363–364.
289. Wandschneider W, Deutsch M. Fatal fungal infection of
an ascending aortic graft. Thorac Cardiovasc Surg 1995; 43:
217–219.
290. Garcı´a Fuster R, Clara´ A, di Stefano S, Legarra J, Sarralde
JA. An unusual vascular graft infection by Aspergillus. A
case report and literature review. Angiology 1999; 50: 169–
173.
291. Marroni M, Cao A, Repetto A, Prattichizzo L, Parlani G,
Fiorio M. Aspergillus ﬂavus infection of an aortic bypass.
Eur J Clin Microbiol Infect Dis 2001; 20: 439–441.
292. Carlson GL, Mughal MM, Birch M, Denning DW. As-
pergillus wound infection following laparostomy. J Infect
1996; 33: 119–121.
293. Nenoff P, Horn LC, Schwenke H, Mierzwa M, Rieske K,
Haustein UF. Invasive mould infections in the University
Clinics of Leipzig during the period from 1992 to 1994.
Mycoses 1996; 39 (suppl 1): 107–112.
294. Vairani G, Rebeschini R, Barbazza R. Hepatic and sub-
cutaneous abscesses due to aspergillosis. Initial diagnosis
of a case by intraoperative ﬁne needle aspiration cytol-
ogy. Acta Cytol 1990; 34: 891–894.
295. Erdman SH, Barber BJ, Barton LL. Aspergillus cholangitis:
a late complication after Kasai portoenterostomy. J Pediatr
Surg 2002; 37: 923–925.
296. Davies SP, WebbWJ, Patou G, Murray WK, Denning DW.
Renal aspergilloma—a case illustrating the problems
of medical therapy. Nephrol Dial Transplant 1987; 2:
568–572.
297. Kusne S, Torre-Cisneros J, Manez R et al. Factors associ-
ated with invasive lung aspergillosis and the signiﬁcance
of positive Aspergillus culture after liver transplantation.
J Infect Dis 1992; 166: 1379–1383.
298. Sartin JS, Wilhelm MP, Keating MR, Batts K, Krom RA. A
case of Aspergillus fumigatus peritonitis complicating liver
transplantation. Eur J Clin Microbiol Infect Dis 1994; 13: 25–
28.
299. Maran˜es A, Portoles J, Blanco J et al. Aspergillus infection
of a renal allograft without evidence of a site of origin.
Nephrol Dial Transplant 1996; 11: 1639–1642.
300. Woods GL, Wood RP, Shaw BW. Aspergillus endocarditis
in patients without prior cardiovascular surgery: report
of a case in a liver transplant recipient and review. Rev
Infect Dis 1989; 11: 263–272.
301. Paterson DL, Dominguez EA, Chang FY, Snydman DR,
Singh N. Infective endocarditis in solid organ transplant
recipients. Clin Infect Dis 1998; 26: 689–694.
302. Kaplan R, Duncalf D, Cizmar S. Aspergillus pancarditis
and cardiac arrest during anesthesia. Anesth Analg 1981;
60: 440–444.
303. Viertel A, Ditting T, Pistorius K, Geiger H, Scheuermann
EH, Just-Nubling G. An unusual case of Aspergillus
endocarditis in a kidney transplant recipient. Transplan-
tation 1999; 68: 1812–1813.
304. Marı´n P, Garcia-Martos P, Garcia-Doncel A et al. Endo-
carditis by Aspergillus fumigatus in a renal transplant.
Mycopathologia 1999; 145: 127–129.
305. Myerowitz RL, Friedman R, Grossman WL. Mycotic
‘mycotic aneurysm’ of the aorta due to Aspergillus
fumigatus. Am J Clin Pathol 1971; 55: 241–246.
1074 Clinical Microbiology and Infection, Volume 12 Number 11, November 2006
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 1060–1076
306. Haddad SH, Arabi YM, Memish ZA, Al-Shimemeri AA.
Nosocomial infective endocarditis in critically ill patients:
a report of three cases and review of the literature. Int J
Infect Dis 2004; 8: 210–216.
307. Elzi L, Laifer G, Bremerich J, Vosbeck J, Mayr M. Invasive
aspergillosis with myocardial involvement after kidney
transplantation. Nephrol Dial Transplant 2005; 20: 631–634.
308. Alvarez L, Calvo E, Abril C. Articular aspergillosis: case
report. Clin Infect Dis 1995; 20: 457–460.
309. Franco M, Van Elslande L, Robino C et al. Aspergillus
arthritis of the shoulder in a renal transplant recipient.
Failure of itraconazole therapy. Rev Rhum Engl Ed 1995;
62: 215–218.
310. Cassuto-Viguier E, Mondain JR, Van Elslande L et al.
Fatal outcome of Aspergillus fumigatus arthritis in a renal
transplant recipient. Transplant Proc 1995; 27: 2461.
311. Ingwer I, McLeish KR, Tight RR, White AC. Aspergillus
fumigatus epidural abscess in a renal transplant recipient.
Arch Intern Med 1978; 138: 153–154.
312. Salvalaggio PR, Bassetti M, Lorber MI et al. Aspergillus
vertebral osteomyelitis after simultaneous kidney–
pancreas transplantation. Transpl Infect Dis 2003; 5:
187–190.
313. Taillandier J, Alemanni M, Cerrina J, Le Roy Ladurie F,
Dartevelle P. Aspergillus osteomyelitis after heart–lung
transplantation. J Heart Lung Transplant 1997; 16: 436–438.
314. Kaneko J, Sugawara Y, Makuuchi M. Aspergillus osteo-
myelitis after liver transplantation. Liver Transpl 2002; 8:
1073–1075.
315. Tang TJ, Janssen HL, van der Vlies CH et al. Aspergillus
osteomyelitis after liver transplantation: conservative or
surgical treatment? Eur J Gastroenterol Hepatol 2000; 12:
123–126.
316. Williams RL, Fukui MB, Meltzer CC, Swarnkar A, John-
son DW, Welch W. Fungal spinal osteomyelitis in the
immunocompromised patient: MR ﬁndings in three
cases. Am J Neuroradiol 1999; 20: 381–385.
317. Cortet B, Richard R, Deprez X et al. Aspergillus spondyl-
odiscitis: successful conservative treatment in 9 cases.
J Rheumatol 1994; 21: 1287–1291.
318. Hummel M, Schuler S, Weber U et al. Aspergillosis with
Aspergillus osteomyelitis and diskitis after heart trans-
plantation: surgical and medical management. J Heart
Lung Transplant 1993; 12: 599–603.
319. Castelli C, Benazzo F, Minoli L, Marone P, Seghezzi R,
Carlizzi CN. Aspergillus infection of the L3–L4 disc space
in an immunosuppressed heart transplant patient. Spine
1990; 15: 1369–1373.
320. De Vuyst D, Surmont I, Verhaegen J, Vanhaecke J. Tibial
osteomyelitis due to Aspergillus ﬂavus in a heart trans-
plant patient. Infection 1992; 20: 48–49.
321. Bridwell KH, Campbell JW, Barenkamp SJ. Surgical
treatment of hematogenous vertebral aspergillus osteo-
myelitis. Spine 1990; 15: 281–285.
322. Byrd BF, Weiner MH, McGee ZA. Aspergillus spinal
epidural abscess. JAMA 1982; 248: 3138–3139.
323. Grossman M. Aspergillosis of bone. Br J Radiol 1975; 48:
57–59.
324. Sonin AH, Stern SH, Levi E. Primary Aspergillus osteo-
myelitis in the tibia of an immunosuppressed man. Am J
Roentgenol 1996; 166: 1277–1279.
325. Delmas Y, Merville P, Dousset V, Dervau-Durieux L,
Morel D, Potaux L. A renal transplant recipient with
acute paraparesis due to an Aspergillus epidural abscess.
Nephrol Dial Transplant 1997; 12: 2185–2187.
326. Jeevanandam V, Smith CR, Rose EA, Malm JR, Hugo NE.
Single-stage management of sternal wound infections.
J Thorac Cardiovasc Surg 1990; 99: 256–262.
327. Byl B, Jacobs F, Antoine M et al. Mediastinitis caused by
Aspergillus fumigatus with ruptured aortic pseudoaneu-
rysm in a heart transplant recipient: case study. Heart
Lung 1993; 22: 145–147.
328. Levin T, Suh B, Beltramo D, Samuel R. Aspergillus
mediastinitis following orthotopic heart transplantation:
case report and review of the literature. Transpl Infect Dis
2004; 6: 129–131.
329. Forestier E, Remy V, Lesens O et al. A case of Aspergillus
mediastinitis after heart transplantation successfully trea-
ted with liposomal amphotericin B, caspofungin and vor-
iconazole. Eur J Clin Microbiol Infect Dis 2005; 24: 347–349.
330. Truppman ES, Ellenby JD, Schwartz BM. Fungi in and
around implants after augmentation mammaplasty. Plast
Reconstr Surg 1979; 64: 804–806.
331. Williams K, Walton RL, Bunkis J. Aspergillus colonization
associated with bilateral silicone mammary implants.
Plast Reconstr Surg 1983; 71: 260–261.
332. Rosenblatt WB, Pollock A. Aspergillus ﬂavus cultured from
a saline-ﬁlled implant. Plast Reconstr Surg 1997; 99: 1470–
1472.
333. He´ry G, Hu W, Jestin N, Lagarde N, Le Flohic AM.
Aspergillus fumigatus infection associated with mammary
prosthesis. J Mycol Med 2002; 12: 193–195.
334. Saray A, Kilic D, Kaygusuz S, Boyunaga H, Ozluk O.
Fungal growth inside saline-ﬁlled implants and the role
of injection ports in fungal translocation: in vitro study.
Plast Reconstr Surg 2004; 114: 1170–1178.
335. Brown MH, Markus YM, Belchetz B, Vearncombe M,
Semple JL. Microbial growth in saline breast implants
and saline tissue expanders. Plast Reconstr Surg 2002; 109:
2242–2244.
336. Young VL, Hertl MC, Murray PR, Jensen J, Witt H, Schorr
MW. Microbial growth inside saline-ﬁlled breast
implants. Plast Reconstr Surg 1997; 100: 182–196.
337. Coady MSE, Gaylor J, Knight SL. Fungal growth within a
silicone tissue expander: Case report. Br J Plast Surg 1995;
48: 428–430.
338. Heinemann S, Symoens F, Gordts B, Jannes B, Nolard N.
Environmental investigations and molecular typing of
Aspergillus ﬂavus during an outbreak of post-operative
infections. J Hosp Infect 2004; 57: 149–155.
339. Diaz-Guerra TM, Mellado E, Cuenca-Estrella M, Gaz-
telurrutia L, Navarro JI, Tudela JL. Genetic similarity
among one Aspergillus ﬂavus strain isolated from a patient
who underwent heart surgery and two environmental
strains obtained from the operating room. J Clin Microbiol
2000; 38: 2419–2422.
340. Dharan S, Pittet D. Environmental controls in operating
theatres. J Hosp Infect 2002; 51: 79–84.
341. Babb JR, Lynam P, Ayliffe GAJ. Risk of airborne trans-
mission in an operating theater containing four ultraclean
air units. J Hosp Infect 1995; 31: 159–168.
342. Barnes RA, Rogers TR. Control of an outbreak of
nosocomial aspergillosis by laminar air-ﬂow isolation.
J Hosp Infect 1989; 14: 89–94.
343. Rhame FS. Prevention of nosocomial aspergillosis. J Hosp
Infect 1991; 18 (suppl A): 466–472.
Pasqualotto and Denning Post-operative aspergillosis 1075
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 1060–1076
344. Walmsley S, Devi S, King S, Schneider R, Richardson S,
Ford-Jones L. Invasive Aspergillus infections in a pediatric
hospital: a ten-year review. Pediatr Infect Dis 1993; 12:
673–682.
345. Pittet D, Ducel G. Infectious risk factors related to oper-
ating rooms. Infect ControlHospEpidemiol 1994; 15: 456–462.
346. Sehulster LM, Chinn RYW, Arduino MJ et al. Guidelines
for environmental infection control in health-care facilities.
Recommendations from CDC and the Healthcare Infection
Control Practices Advisory Committee (HICPAC). Chicago
IL: American Society for Healthcare Engineer-
ing ⁄American Hospital Association, 2004.
347. Faure O, Fricker-Hidalgo H, Lebeau B, Mallaret MR,
Ambroise-Thomas P, Grillot R. Eight-year surveillance of
environmental fungal contamination in hospital oper-
ating rooms and haematological units. J Hosp Infect 2002;
50: 155–160.
348. Roy M-C. The operating theater: a special environmental
area. In: Wenzel RP, ed., Prevention and control of nosoco-
mial infections, 3rd edn. Baltimore, MD: William &
Wilkins, 1997; 515–538.
349. Humphreys H. Positive-pressure isolation and the pre-
vention of invasive aspergillosis. What is the evidence?
J Hosp Infect 2004; 56: 93–100.
350. Kelkar U, Bal AM, Kulkarni S. Fungal contamination of
air conditioning units in operating theatres in India.
J Hosp Infect 2005; 60: 81–84.
1076 Clinical Microbiology and Infection, Volume 12 Number 11, November 2006
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 1060–1076
